Press Release: Health Logic Interactive Announces the Resignation of CEO and Appoints New Interim CEO to Focus on New Acquisition Targets
Press Release: Health Logic Interactive Announces the Resignation of CEO and Appoints New Interim CEO to Focus on New Acquisition Targets
Health Logic Interactive Announces the Resignation of CEO and Appoints New Interim CEO to Focus on New Acquisition Targets
Health Logic Interactive宣佈CEO辭職並任命新的臨時CEO專注於新的收購目標
Canada NewsWire
加拿大新聞通訊社
CALGARY, AB, Nov. 16, 2021
阿肯色州卡爾加里，2021年11月16日
CALGARY, AB, Nov. 16, 2021 /CNW/ - Health Logic Interactive Inc. ("Health Logic" or the "Company") (TSXV: CHIP.H) (OTCPK: CHYPF) is pleased to announce the hiring of Mr. Harrison Ross as interim Chief Executive Officer for Health Logic and the resignation of Mr. David Barthel. In his role Mr. Ross will look to finalize the sale of the Company's wholly owned subsidiary, My Health Logic Inc. ("My Health Logic"), to Marizyme Inc. ("Marizyme") and begin the new strategic direction of the Company.
卡爾加里，AB，2021年11月16日/cnw/-Health Logic Interactive Inc.(以下簡稱“Health Logic”或“公司”)(多倫多證券交易所股票代碼：CHIP.H)(場外交易市場代碼：CHYPF)高興地宣佈聘請哈里森·羅斯先生擔任健康邏輯臨時首席執行官，David Barthel先生辭職。羅斯先生將負責敲定將公司全資子公司My Health Logic Inc.(“My Health Logic”)出售給Marizyme Inc.(“Marizyme”)的交易，並開始公司的新戰略方向。
Mr. Ross, a charted financial accountant (CFA), was previously the Company's CFO and is well versed in the Company history and will be in charge of leading the future direction of the Company. As the previous CFO of Health Logic, he was essential to the initial building of the business, helping restructure the previous shell, financing the Company, and streamlining of the business' operations to help develop MATLOC 1 and the accompanying lab-on-chip technology. The sale of My Health Logic to Marizyme is expected to be complete this December 2021.
羅斯先生是一名特許財務會計師(CFA)，曾任公司首席財務官，精通公司歷史，將負責領導公司未來的發展方向。作為Health Logic的前首席財務官，他對業務的初步建立至關重要，幫助重組了之前的外殼，為公司提供了資金，並精簡了業務運營，以幫助開發MATLOC 1和隨之而來的芯片實驗室技術。將My Health Logic出售給Marizyme的交易預計將於2021年12月完成。
While the expected sale of My Health Logic closes, the Company will be actively looking for other acquisition and financing opportunities to prepare for a successful reactivation to the Tier ll of the TSX Venture Exchange (the "TSXV") based on continued listing requirements.
隨着My Health Logic的預期出售完成，本公司將積極尋找其他收購和融資機會，為根據持續的上市要求成功重新啟動多倫多證券交易所創業板(“多倫多證券交易所”)第II層做準備。
In addition to Mr. Ross' move from CFO to CEO, all directors of Health Logic will remain directors of the Company, George Kovalyov will move from COO to CFO of the Company, and David Barthel will resign as CEO of the Company and transition to Marizyme as their new CEO. Health Logic thanks Mr. Barthel for his excellent efforts in leading the Company and believe it is in the best interests of the Company's shareholders that David become CEO of Marizyme to advance both MATLOC and Marizyme's other exciting technologies including their flagship DuraGraft product.
除了羅斯先生從首席財務官升任首席執行官外，Health Logic公司的所有董事將繼續擔任公司董事，喬治·科瓦廖夫將從首席運營官升任公司首席財務官，大衞·巴特爾將辭去公司首席執行官一職，並過渡到Marizyme擔任他們的新首席執行官。Health Logic感謝Barthel先生在領導公司方面所做的出色努力，並相信David成為Marizyme的首席執行官符合公司股東的最佳利益，他將推動MATLOC和Marizyme的其他令人興奮的技術，包括他們的旗艦產品DuraGraft。
Mr. Ross' accomplishments include being CFO at DC Acquisition Corp., a Capital Pool Company listed on the TSXV that raised $2.5 million on its initial public offering before successfully completing its qualifying transaction of Kiaro Holdings Corp. (TSXV: KO). Mr. Ross has helped manage over $500 million in assets at Duncan Ross and Associates and was an analyst at the Family Office Belkorp Industries. Now, Mr. Ross is bringing his expertise to Health Logic as the interim CEO.
羅斯先生的成就包括在DC Acquisition Corp.擔任首席財務官，DC Acquisition Corp.是在多倫多證券交易所上市的Capital Pool Company，在成功完成對Kiaro Holdings Corp.(多倫多證券交易所代碼：KO)的合格交易之前，在首次公開募股(IPO)中籌集了250萬美元。羅斯曾幫助管理鄧肯·羅斯公司(Duncan Ross And Associates)超過5億美元的資產，並曾在家族理財室貝爾科普工業公司(Family Office Belkorp Industries)擔任分析師。現在，羅斯將把他的專業知識帶到Health Logic擔任臨時首席執行長。
Mr. Ross is also a director of Codebase Ventures Inc. (CSE: CODE), an investment issuer focused on early stage investments in sectors with significant upside.
羅斯也是Codebase Ventures Inc.(CSE：CODE)的董事，該公司是一家投資發行商，專注於具有重大上行空間的行業的早期投資。
About the Company
關於本公司
Health Logic Interactive, through its wholly owned operating subsidiary My Health Logic, has pursued the development and commercialization of consumer focused handheld point-of-care diagnostic devices that connect to patient's smartphones and digital continued care platforms. For more information visit us at: www.healthlogicinteractive.com.
Health Logic Interactive公司通過其全資擁有的運營子公司My Health Logic，致力於開發以消費者為中心的手持式看護點診斷設備，並將其商業化，這些設備連接到患者的智能手機和數字持續護理平臺。欲瞭解更多信息，請訪問我們的網站：www.Health logicinteractive.com。
Further information regarding Health Logic Interactive Inc. and its disclosure documents are available on SEDAR at www.sedar.com.
欲瞭解有關Health Logic Interactive Inc.及其披露文件的更多信息，請訪問SEDAR網站www.sedar.com。
Neither the TSX Venture Exchange nor its regulation services provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
多倫多證券交易所創業板交易所及其監管服務提供商(該術語在多倫多證券交易所創業板政策中定義)均不對本新聞稿的充分性或準確性承擔責任。
Cautionary Notes
注意事項
Certain statements contained in this press release constitute "forward-looking statements". All statements other than statements of historical fact contained in this press release, including, without limitation, those regarding: the sale of the Company's wholly-owned subsidiary My Health Logic; the Company's ability to identify and acquire new business opportunities; the Company's expectations that it will be able to complete a financing necessary to acquire a new business opportunity; the Company's expectation that it will successfully reactivate onto Tier II of the TSXV; Marizyme's ability to progress its technologies; and the Company's strategy, plans, objectives, goals and targets, and any statements preceded by, followed by or that include the words "believe", "expect", "aim", "intend", "plan", "continue", "will", "may", "would", "anticipate", "estimate", "forecast", "predict", "project", "seek", "should" or similar expressions or the negative thereof, are forward-looking statements.
本新聞稿中包含的某些陳述屬於“前瞻性陳述”。本新聞稿中除歷史事實陳述外的所有陳述，包括但不限於：公司全資子公司My Health Logic的出售；公司發現和收購新商機的能力；公司對能夠完成獲得新商機所需的融資的期望；公司對成功重新啟動TSXV二級市場的期望；Marizyme取得技術進步的能力；本公司的戰略、計劃、目標、目標和指標，以及任何前後帶有“相信”、“預期”、“目標”、“打算”、“計劃”、“繼續”、“將”、“可能”、“將”、“預期”、“估計”、“預測”、“預測”、“項目”、“尋求”、“應該”或類似表述或其否定的表述，均屬前瞻性表述。
These statements are not historical facts but instead represent only the Company's expectations, estimates and projections regarding future events. These statements are not guarantees of future performance and involve assumptions, risks and uncertainties that are difficult to predict. Therefore, actual results may differ materially from what is expressed, implied or forecasted in such forward-looking statements. Additional factors that could cause actual results, performance or achievements to differ materially include, but are not limited to the risk factors discussed in the Company's Management's Discussion and Analysis for the year ended December 31, 2020. Management provides forward-looking statements because it believes they provide useful information to investors when considering their investment objectives and cautions investors not to place undue reliance on forward-looking information. Consequently, all of the forward-looking statements made in this press release are qualified by these cautionary statements and other cautionary statements or factors contained herein, and there can be no assurance that the actual results or developments will be realized or, even if substantially realized, that they will have the expected consequences to, or effects on, the Company. These forward-looking statements are made as of the date of this press release and the Company assumes no obligation to update or revise them to reflect subsequent information, events or circumstances or otherwise, except as required by law.
這些陳述不是歷史事實，而僅代表公司對未來事件的預期、估計和預測。這些陳述不是對未來業績的保證，涉及難以預測的假設、風險和不確定性。因此，實際結果可能與這些前瞻性陳述中表達、暗示或預測的內容大不相同。其他可能導致實際結果、業績或成就大不相同的因素包括但不限於公司管理層在截至2020年12月31日的年度的討論和分析中討論的風險因素。管理層提供前瞻性陳述，因為它認為這些陳述在考慮他們的投資目標時為投資者提供了有用的信息，並告誡投資者不要過度依賴前瞻性信息。因此，本新聞稿中的所有前瞻性陳述都受到這些警告性聲明和其他警告性聲明或本文中包含的因素的限制，不能保證實際結果或發展會實現，或者即使實質上實現了，也不能保證它們會對公司產生預期的後果或影響。這些前瞻性陳述是截至本新聞稿發佈之日作出的，除非法律另有要求，否則公司沒有義務更新或修改這些陳述，以反映後續信息、事件或情況或其他情況。
SOURCE Health Logic Interactive Inc.
來源：Health Logic Interactive Inc.
View original content to download multimedia: http://www.newswire.ca/en/releases/archive/November2021/16/c3808.html
觀看原創內容下載多媒體：http://www.newswire.ca/en/releases/archive/November2021/16/c3808.html
/CONTACT:
/聯繫方式：
George Kovalyov, Director, info@healthlogicinteractive.com, 1-877-456-4424 CO: Health Logic Interactive Inc.
電子郵件：info@Health logicinteractive.com總監喬治·科瓦廖夫(George Kovalyov)電話：1-877-456-4424 CO：Health Logic Interactive Inc.
/Web site: https://www.healthlogicinteractive.com/
網址：https://www.healthlogicinteractive.com/
Copyright CNW Group 2021
版權所有CNW集團2021
譯文內容由第三人軟體翻譯。